Repose Furniture Limited

Repose Furniture Limited designs and manufactures bespoke healthcare and riser recliner chairs, focusing on comfort and support for individuals with mobility challenges, especially in the healthcare sector. Their products are crafted to enhance user experience and accessibility. Repose Furniture Limited, founded in 1999, specializes in the production of bespoke healthcare and riser recliner chairs. The company operates from the UK and has undergone no significant pivots in its business strategy.

It has not been noted as a subsidiary or having subsidiaries. The founder's specific history is not mentioned, and there are no previous companies listed. In January 2021, Repose Furniture was acquired by Prism UK Medical Ltd. , a portfolio company of Limerston Capital, with financial terms undisclosed.

The company has completed one deal to date and continues to operate under its established brand. Repose Furniture specializes in designing and manufacturing bespoke healthcare and riser recliner chairs, with a focus on comfort and support for users with medical conditions affecting mobility. Their product range includes standard and custom-made riser recliner chairs, healthcare chairs, and additional complementary furniture to meet specific user needs. The company primarily caters to elderly individuals, patients with chronic pain, and healthcare facilities seeking tailored seating solutions.

In the most recent year of 2023, Repose Furniture generated revenue of USD 12. 83 mn with an EBITDA of USD 1. 30 mn. The company utilizes a direct-to-consumer sales model along with business-to-business sales, catering to healthcare providers and care homes.

Their pricing structure is bespoke, reflecting the custom-made nature of their offerings, allowing them to meet specific client needs. Repose Furniture is actively planning to expand its product line and geographic reach. They are currently designing new healthcare seating solutions to launch later in 2024, targeting both domestic and international markets. The recent acquisition by Prism UK Medical Ltd.

will provide resources to support these initiatives and facilitate entry into new markets, aiming for broader distribution by the end of 2025. The strategic goals will leverage the bespoke model to enhance service delivery and expand its client base in the healthcare sector.